MoneyWeek

There's a reason MoneyWeek is Britain's best-selling financial magazine. We exist to help you ground your portfolio so that it keeps your money safe during rough patches and growing in the good times. We don't just look at how to maximise your returns and limit your losses, we also like to look at how you can keep more of the money you've made.

Week-in, week-out we'll guide you through the financial world as it changes, alerting you to all the opportunities to profit and dangers to avoid, as they appear. Income strategies, rising-star companies, the best funds and trusts, clever ways to preserve your wealth during market turmoil... you will get the best ideas from the sharpest financial minds and investing professionals in Britain.

From the editor-in-chief...

The long virtual arm of the law

Good week for

Bad week for

Get set for the next inflation scare

Asia’s tigers have stopped growling

Will UK house prices stay high?

Viewpoint

Spacs come under attack

A “meme” stock’s enduring rally

MoneyWeek’s comprehensive guide to this week’s share tips

An American view

IPO watch

City talk

A spoonful of sweetener... • ...has proved an enticing morsel for private-equity group KPS Capital Partners, which is buying part of Tate & Lyle. Matthew Partridge reports

Pandemic plunderers target Daily Mail

Boris Johnson’s latest reverse ferret • The PM loses his nerve and bounds Freedom Day within nannying limits. Emily Hohler reports

Covid-19 cases spike in Europe

Taliban surges as US pulls out • Withdrawing troops from Afghanistan is a risk for Biden. Matthew Partridge reports

Haiti teeters on the verge of collapse

Betting on politics

News

The way we live now: paying through the nose for “ethically sourced cocaine”

The dawn of a new space age • Jostling to be the first billionaire in space might seem to be a daft ego trip, but it is all part of a broader space industry with important real-world applications. Simon Wilson reports

Build your own ultimate index • Efforts to build the “ultimate” tracker fund reveal how easy it is to over-complicate your asset allocation

I wish I knew what asset allocation was, but I’m too embarrassed to ask

Guru watch

The perils of being a landlord • Companies looking to muscle in on the home rental market should think twice

Who’s getting what

Nice work if you can get it

Best of the financial columnists

Money talks

Commodities are on a roll • Profiting from raw materials isn’t as easy as you might think. A new ETF, however, is worth a look

The costs of “net zero”

Living with a monetary disease

Beware: left turn ahead

Lockdown zealots crushed the economy

The doctor will see you now • The pandemic has vastly accelerated the shift towards telehealth, making Cigna a long-term buy

An absurdly cheap healthcare winner

A broker set to bounce • TP ICAP is cheap, expanding steadily and restoring its dividend

Trading techniques... beware the death cross

How my tips have fared

A great leap forward in the war against Alzheimer’s disease • The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs. That bodes well for Huntingdon’s and Parkinson’s sufferers too

Expect pricier premiums • Car and home insurance will be more expensive post-reopening

Regulator targets transfers • The FCA wants to make it harder for people to leave final-salary schemes

More savers hit by annual allowance

Savers failing to spot pension scams

Companies...